Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-04-038512
Filing Date
2004-12-06
Accepted
2004-12-06 19:00:23
Documents
1
Period of Report
2004-12-01

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1489
  Complete submission text file 0001104659-04-038512.txt   3309
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Issuer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 150 FIELD DR. SUITE 195 LAKE FOREST IL 60045
Business Address 847-295-8678
Binion Steven B (Reporting) CIK: 0001310664 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12493 | Film No.: 041187149